CeloNova BioSciences
CeloNova BioSciences (Booth 1408) is debuting the technology behind the Catania coronary stent system, which is only approved in Europe, featuring a NanoThin Polyzene-F surface treatment.

The Catania stent surface has been modified with Polyzene-F, a synthesized, inorganic, biocompatible polymer that is anti-thrombotic, anti-inflammatory and bacterial-resistant, to promote healthy endothelial cell growth without stimulating platelet activation.

The cobalt-chromium Catania stent features a modified open-cell design and is mounted on a semi-compliant balloon. It is available in 60 sizes: in lengths from 8mm to 38mm and in eight diameters, from 2.0 mm to 3.5 mm, in quarter steps, and 4.0 mm. The proprietary nanothin Polyzene-F polymer can be applied to or mixed with other substances to allow for a range of bioscience and industrial applications on a multitude of substrates, including other polymers, metals and ceramics.

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup